You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ONC201

Showing 26 - 50 of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unspecified Adult Solid Tumor Trial in New Brunswick (Oral ONC201, pharmacological study, laboratory biomarker analysis)

Completed
  • Unspecified Adult Solid Tumor
  • Oral ONC201
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
May 20, 2019

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Multiple Myeloma Trial in Worldwide (REGN5458)

Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +26 more
Aug 16, 2022

Carcinoma Breast Stage I, HER2 Positive Breast Cancer Trial in Mumbai (Trastuzumab, Placebo)

Recruiting
  • Carcinoma Breast Stage I
  • HER2 Positive Breast Cancer
  • Mumbai, India
    Tata Memorial Centre
Apr 26, 2022

Oral Lichen Planus Trial (6-Gingerol, Triamcinolone Acetonide 0.1% Oromucosal Paste)

Not yet recruiting
  • Oral Lichen Planus
  • 6-Gingerol
  • Triamcinolone Acetonide 0.1% Oromucosal Paste
  • (no location specified)
May 22, 2023

Small Cell Lung Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Carboplatin,

Completed
Has Results
  • Small Cell Lung Carcinoma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +3 more
  • Fort Myers, Florida
  • +113 more
Nov 30, 2022

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anchorage, Alaska
  • +495 more
Jun 15, 2022

Recurrent, Platinum-resistant Ovarian Cancer Trial in Milan (Decitabine, Carboplatin, Pegylated Liposomal Doxorubicin)

Recruiting
  • Recurrent, Platinum-resistant Ovarian Cancer
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Sep 3, 2021

Breast Cancer Trial in United States (Poziotinib)

Completed
Has Results
  • Breast Cancer
  • Huntsville, Alabama
  • +34 more
Feb 28, 2022

Cutaneous T-Cell Lymphoma Trial in Worldwide (KW-0761, Vorinostat)

Completed
Has Results
  • Cutaneous T-Cell Lymphoma
  • Birmingham, Alabama
  • +72 more
Jul 22, 2022

Neutropenia Trial in Worldwide (tbo-filgrastim)

Completed
Has Results
  • Neutropenia
  • Long Beach, California
  • +32 more
Dec 8, 2021

Small Cell Lung Cancer Trial in Worldwide (Placebo for dexamethasone, Placebo for rovalpituzumab tesirine, Rovalpituzumab

Terminated
Has Results
  • Small Cell Lung Cancer
  • Placebo for dexamethasone
  • +3 more
  • Huntsville, Alabama
  • +307 more
Jul 28, 2021

Non Small Cell Lung Cancer Trial in United States (Pegilodecakin, Pembrolizumab)

Terminated
Has Results
  • Non Small Cell Lung Cancer
  • Huntsville, Alabama
  • +73 more
Jan 15, 2021

Castration-resistant Prostate Cancer Trial in Fairfax (Calcitriol, Ketoconazole, Hydrocortisone)

Terminated
Has Results
  • Castration-resistant Prostate Cancer
  • Calcitriol, Ketoconazole, Hydrocortisone
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Jan 19, 2021

Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)

Terminated
Has Results
  • Advanced Solid Tumors
  • Los Angeles, California
  • +29 more
May 21, 2022

Breast Cancer Trial in Sacramento (Ashwagandha, Placebo)

Unknown status
  • Breast Cancer
  • Sacramento, California
    Sutter Cancer Center
Sep 13, 2019

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab, Sorafenib)

Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • Phoenix, Arizona
  • +118 more
Jun 14, 2022

Metastatic Breast Cancer Trial in Worldwide (Pertuzumab, Placebo, Trastuzumab)

Completed
Has Results
  • Metastatic Breast Cancer
  • Scottsdale, Arizona
  • +321 more
Dec 12, 2019

Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive Trial in Worldwide

Completed
Has Results
  • Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
  • Anaheim, California
  • +188 more
Apr 16, 2021

Breast Tumors Trial in Worldwide (Docetaxel, Nab-paclitaxel, Paclitaxel)

Completed
Has Results
  • Breast Neoplasms
  • Algiers, Algeria
  • +298 more
Aug 31, 2020

Squamous Cell NSCLC Trial in Worldwide (Abraxane (Induction), Carboplatin (Induction), Abraxane (Maintenance))

Completed
Has Results
  • Squamous Cell Carcinoma, Non-Small-Cell Lung
  • Abraxane (Induction)
  • +3 more
  • Huntsville, Alabama
  • +118 more
Aug 14, 2020

Lymphoblastic Leukemia, Acute Trial in Memphis, Fort Worth (Prednisone, Dexamethasone, Vincristine, Daunorubicin, Doxorubicin,

Completed
Has Results
  • Lymphoblastic Leukemia, Acute
  • Prednisone, Dexamethasone, Vincristine, Daunorubicin
  • +5 more
  • Memphis, Tennessee
  • +1 more
Sep 9, 2020

Breast Cancer Trial in Worldwide (Paclitaxel, BKM120 matching , BKM120)

Completed
Has Results
  • Breast Cancer
  • Chandler, Arizona
  • +112 more
Jan 27, 2017

Metastatic Patients Treated With mTOR Inhibitor Everolimus

Unknown status
  • SOLID TUMOR
    • Rozzano, MI, Italy
      Istituto Clinico Humanitas
    Feb 9, 2017

    Pancreas Cancer Trial in Dallas (anakinra, Oxaliplatin, Irinotecan)

    Unknown status
    • Pancreas Cancer
    • Dallas, Texas
      Baylor Sammons Cancer Center
    Jan 30, 2017